Document:

First Amendment to Loan Agreement

 Exhibit 10.207 
  
 FIRST AMENDMENT TO LOAN AGREEMENT 
  
 THIS FIRST AMENDMENT TO LOAN AGREEMENT (the “Amendment”), dated as of July 1, 2004, is made by and among SPOTLIGHT HEALTH, INC. (the
“Borrower”), PHARMACEUTICAL PRODUCT DEVELOPMENT, INC., (the “Guarantor”) and BANK OF AMERICA, N.A. (the “Bank”). 
  
 RECITALS: 
  
 A. The Borrower, the Guarantor and the Bank entered into that certain Loan Agreement, dated as of July 1, 2003 (the “Loan Agreement”).

  
 B. The Borrower, the Guarantor and the Bank have agreed to
amend the Loan Agreement as set forth herein. 
  
 NOW THEREFORE,
the parties hereto agree as follows: 
  
 1. Section 1.01 of the
Loan Agreement is amended by deleting the definition of “Termination Date” and replacing it with the following definition: 
  
 “Termination Date” means June 30, 2005, or such later date as to which the Bank may agree in its sole discretion. 
  
 2. Except as hereby modified, all the terms and provisions of the Loan
Agreement and exhibits thereto remain in full force and effect. 
  
 3. The Borrower and the Guarantor acknowledge and agree that there are no defenses, setoffs or counterclaims available to them with respect to the performance of their obligations under the Loan Agreement (including, without limitation, the
Guarantor’s obligations under Section 3 of the Loan Agreement). 
  
 4. The Borrower and the Guarantor will execute such additional documents as are reasonably requested by the Bank to reflect the terms and conditions of this Amendment and will cause to be delivered such certificates, legal opinions and
other documents as are reasonably required by the Bank. In addition, the Borrower and the Guarantor will pay all costs and expenses in connection with the preparation, execution and delivery of the documents executed in connection with this
transaction, including, without limitation, the reasonable fees and out-of-pocket expenses of special counsel to the Bank as well as any and all filing and recording fees and stamp and other taxes with respect thereto and to save the Bank harmless
from any and all such costs, expenses and liabilities. 
  

 1 

 5. This Amendment may be executed in any number of counterparts, each of which when so executed and
delivered shall be deemed an original, and it shall not be necessary in making proof of this Amendment to produce or account for more than one counterpart. 
  
 6. This Amendment and all other documents executed pursuant to the transactions contemplated herein shall be deemed to be contracts made under, and for
all purposes shall be construed in accordance with, the internal laws and judicial decisions of the State of North Carolina. The Borrower and the Guarantor hereby submit to the jurisdiction and venue of the state and federal courts of North Carolina
for the purposes of resolving disputes hereunder and thereunder or for purposes of collection. 
  
 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed by their fully authorized officers as of the day and year first above written. 
  

					
	BORROWER:	 	SPOTLIGHT HEALTH, INC., a Delaware corporation
			
	 	 	By:	 	 /s/ T. Spring

	 	 	Name:	 	T. Spring
	 	 	Title:	 	Chief Financial Officer
		
	GUARANTOR:	 	PHARMACEUTICAL PRODUCT DEVELOPMENT, INC., a North Carolina corporation
			
	 	 	By:	 	 /s/ Fredric N. Eshelman

	 	 	Name:	 	Fredric N. Eshelman
	 	 	Title:	 	Chief Executive Officer
		
	BANK:	 	BANK OF AMERICA, N.A.
			
	 	 	By:	 	 /s/ J. Thomas Johnson, Jr.

	 	 	Name:	 	J. Thomas Johnson, Jr.
	 	 	Title:	 	Senior Vice President

  

 2Employment Agreement

 Exhibit 10.208 
  
 EMPLOYMENT AGREEMENT 
  
 THIS AGREEMENT (the “Agreement”), is made as of the 16th day of July, 2004, by and between PPD Development, LP (the “Company”), a Texas limited partnership whose mailing address for notice purposes is 3151 South Seventeenth Street, Wilmington,
North Carolina 28412, Attention: Chief Executive Officer – Pharmaceutical Product Development, Inc., and Colin Shannon (“Employee”), an individual whose mailing address for notice purposes is 3151 South Seventeenth Street, Wilmington,
North Carolina 28412. 
  
 RECITALS 
  
 A. The Company is a clinical research organization which, among other
services, provides Phases I through IV development services to pharmaceutical, biotechnology and medical device companies (the “Business”). 
  
 B. The Company desires to employ Employee and Employee desires to be employed by the Company, all upon the terms and conditions set forth herein.

  
 NOW, THEREFORE, in consideration of the foregoing
recitals, the mutual covenants of the parties hereinafter set forth and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows: 
  
 ARTICLE 1 
 EMPLOYMENT AND DUTIES 
  
 1.1 Engagement of Employee. The Company agrees to employ Employee and Employee accepts such employment pursuant and subject to the terms and conditions of this Agreement. 
  
 1.2. Duties and Powers. During the Employment Period (as defined
herein), Employee shall serve as Executive Vice President of Global Clinical Operations and will have such responsibilities, duties and authority, and will render such services for and in connection with the Company and its affiliates as are
customary in such position and as the general partner of the Company and the Chief Executive Officer and President of Pharmaceutical Product Development, Inc. (“PPD”) shall from time to time reasonably direct. Employee shall devote
Employee’s full business time and attention exclusively to the Business of the Company and shall use best efforts to faithfully carry out Employee’s duties and responsibilities hereunder. Employee shall comply with all personnel policies
and procedures of the Company as the same now exist or may be hereafter implemented by the Company from time to time, including those policies contained in the PPD employee manual or handbook which sets forth policies and procedures generally for
employees of PPD and its subsidiaries and affiliates (the “Handbook”) to the extent not inconsistent with this Agreement. 
  

 ARTICLE 2 
 TERM OF EMPLOYMENT 
  
 Employee’s employment under this Agreement shall commence on the date on which Employee receives an L-1 visa from the United States government (the “Effective Date”) and, unless sooner terminated as provided elsewhere in this
Agreement, shall terminate on the second anniversary of the Effective Date (“Initial Employment Period”). This Agreement shall thereafter automatically renew for successive one-year periods, unless either the Company or Employee provides
written notice to the other at least sixty (60) days prior to the termination of any such period stating said party’s desire to terminate this Agreement. The Initial Employment Period and any extension or renewal thereof shall be referred to
herein together as the “Employment Period”. Notwithstanding anything to the contrary contained herein, the Employment Period is subject to termination pursuant to Article 4 hereof. 
  
 ARTICLE 3 
 COMPENSATION AND BENEFITS 
  
 3.1 Compensation. The Company will pay Employee a base salary at the rate of $265,000.00 per annum (the “Base Salary”), payable in accordance with the Company’s regular payroll policy for
salaried employees. The Base Salary of Employee may be subject to increase annually during the Employment Period by the general partner of the Company. The Base Salary for any partial year will be prorated based on the number of days elapsed in such
year during which services were actually performed by Employee. 
  
 3.2 Benefits. Except as provided below, during the Employment Period, Employee shall be eligible to participate in and/or receive benefits under such employee and welfare benefit plans as may be established from time to time by or
for the benefit of employees of the Company, including any profit-sharing, stock purchase, stock option, bonus, disability, pension, group-term life insurance, health insurance and flexible benefit payroll deduction plans, subject in each instance
to Employee meeting all eligibility and qualification requirements of such plans. Until receipt of a green card by Employee from the United States government, Employee shall continue to participate in the pension plan that he is currently
participating in as an employee of PPD Global Limited (the “UK Pension Plan”). Upon receipt of a green card, Employee shall cease participating in the UK Pension Plan and shall be eligible to participate in and/or receive benefits under
the Company’s 401(k) retirement plan as then in effect. 
  
 3.3 Expenses. The Company will reimburse Employee, in accordance with and subject to Employee’s compliance with the Company’s policy, for Employee’s necessary and reasonable out-of-pocket expenses incurred in the
course of performance of Employee’s duties hereunder. All reimbursement of expenses to Employee hereunder shall be conditioned upon presentation of sufficient documentation evidencing such expenses. 
  
 3.4 Vacation and Leave. Employee shall be entitled to the number of
days of “Paid Time Off” (“PTO”) and other leave as may be established from time to time 
  

 2 

 by the Company for the benefit of its employees, subject to Employee’s compliance with the guidelines set forth in
the Handbook. 
  
 3.5 Working Facilities. The Company shall
furnish Employee with such office space, equipment, technical, secretarial and clerical assistance and such other facilities, services and supplies as shall be reasonably necessary to enable Employee to perform the duties required of Employee
hereunder in an efficient and professional manner. 
  
 3.6
Signing Bonus. Upon execution of this Agreement, the Company will pay Employee a bonus in an amount equal to $30,000, of which $20,000 will be grossed up for federal and state income and employment tax purposes. 
  
 ARTICLE 4 
 TERMINATION OF EMPLOYMENT 
  
 4.1 Basis for Termination. Notwithstanding any other provision in this Agreement to the contrary, the Employment Period and Employee’s employment hereunder shall terminate effective on the date indicated
upon the happening of any of the following events: 
  
         a. Upon the death of Employee, effective immediately on the date of death without any notice. 
  
         b. A determination by the Chief Executive Officer of PPD, acting in good faith but made in the sole
discretion of the Chief Executive Officer, that Employee has failed to substantially perform his duties under or otherwise breached any of the material terms of this Agreement, effective upon the date said determination is communicated to Employee
or such later date, if any, as specified by the Chief Executive Officer of PPD. 
  
         c. A determination by the Chief Executive Officer of PPD, acting in good faith but made in the sole discretion of the Chief Executive Officer, that Employee (i) has
become physically or mentally incapacitated and is unable to perform his duties under this Agreement as a result of such disability, which inability continues for a period of sixty (60) days during any twelve-month period hereunder, (ii) has
demonstrated gross negligence or willful misconduct in the execution of his duties, or (iii) has been convicted of a felony, effective upon the date said determination is communicated to Employee or such later date, as specified by the Chief
Executive Officer of PPD. 
  
 4.2 Compensation After
Termination During Employment Period. If the Company shall terminate Employee’s employment during the Employment Period pursuant to Section 4.1 hereof, the Company shall have no further obligations hereunder or otherwise with respect to
Employee’s employment from and after the termination or expiration date, except that the Company shall pay Employee’s Base Salary accrued through the date of termination or expiration and shall provide such benefits as are required by
applicable law. From and after such termination or expiration date, the 
  

 3 

 Company shall continue to have all other rights available hereunder, including without limitation all rights under
Article 5 hereof, and at law or in equity. 
  
 ARTICLE 5

 NON-COMPETITION AND PROPRIETARY INFORMATION COVENANTS 
  
 5.1 Non-Compete. During the Employment Period, Employee hereby agrees that he shall not (a) become an officer,
employee, director, agent, representative, member, associate or consultant of or to a corporation, partnership or other business entity or person, (b) directly or indirectly acquire a proprietary interest in a corporation, partnership or other
business entity or person, or (c) directly or indirectly own any stock in a corporation (other than a publicly traded corporation of which Employee owns less than two percent (2%) of the outstanding stock), in each case which is engaged in the
business of managing clinical research programs for pharmaceutical, biotechnology or medical device companies or in any other business which is developed by PPD Development during the Employment Period anywhere in the world. The parties agree that
the business and operations of PPD Development are global in scope. For that reason, the parties agree that a geographical limitation on the foregoing covenant is not appropriate. 
  
 5.2 Proprietary Agreement. Prior to the Effective Date, Employee shall have executed in favor of the Company its
standard Proprietary Information and Inventions Agreement (the “Proprietary Agreement”). 
  
 ARTICLE 6 
 MISCELLANEOUS 
  
 6.1 Withholding Taxes. All amounts payable under this Agreement,
whether such payment is to be made in cash or other property, shall be subject to withholding for Federal, state and local income taxes, employment and payroll taxes, and other legally required withholding taxes and contributions to the extent
appropriate in the determination of the Company, and Employee shall report all such amounts as ordinary income on Employee’s personal income returns and for all other purposes. 
  
 6.2 Assignment. No party hereto may assign or delegate any of its rights or obligations hereunder without the prior
written consent of the other party hereto; provided, however, that the Company shall have the right to assign all or any part of its rights and obligations under this Agreement (i) to any subsidiary or affiliate of the Company or any surviving
entity following any merger or consolidation of any of those entities with any entity other than the Company, or (ii) in connection with the sale of the Business by the Company. 
  
 6.3 Binding Effect. Except as otherwise expressly provided herein, all covenants and agreements contained in this
Agreement by or on behalf of any of the parties hereto shall be binding upon and inure to the benefit of the respective legal representatives, heirs, successors and permitted assigns of the parties hereto. 
  

 4 

 6.4 Entire Agreement. Except as otherwise expressly set forth herein, this Agreement sets forth
the entire understanding of the parties and supersedes and preempts all prior oral or written understandings and agreements with respect to the subject matter hereof, specifically including but not limited to that certain Employment Agreement dated
April 1, 2003 between PPD Global Limited and Employee which the parties agree will automatically terminate on the Effective Date without any further notice or action. 
  
 6.5 Severability. Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be
effective and valid under applicable law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable law, such provision shall be ineffective only to the extent of such prohibition or invalidity, without
invalidating the remainder of this Agreement. 
  
 6.6
Amendment; Modification. No amendment or modification of this Agreement and no waiver by any party of the breach of any covenant contained herein shall be binding unless executed in writing by the party against whom enforcement of such
amendment, modification or waiver is sought. No waiver shall be deemed a continuing waiver or a waiver in respect of any subsequent breach or default, either of a similar or different nature, unless expressly so stated in writing. 
  
 6.7 Governing Law. This Agreement shall be governed by and construed
and enforced in accordance with the laws of the State of North Carolina, without giving effect to provisions thereof regarding conflict of laws. 
  
 6.8 Arbitration. Any dispute, controversy or claim arising out of or relating to this Agreement, including but not limited to its existence,
validity, interpretation, performance or non-performance or breach, shall be decided by a single neutral arbitrator agreed upon by the parties hereto in Wilmington, North Carolina in binding arbitration pursuant to the commercial arbitration rules
of the American Arbitration Association then in effect. The parties to any such arbitration shall be limited to the parties to this Agreement or any successor thereof. The written decision of the arbitrator shall be final and binding and may be
entered and enforced in any court of competent jurisdiction. Each party waives any right to a jury trial in any such forum. Each party to the arbitration shall pay its fees and expenses, unless otherwise determined by the arbitrator. 
  
 6.9 Notices. All notices, demands or other communications to be given
or delivered hereunder or by reason of the provisions of this Agreement shall be in writing and shall be deemed to have been properly served if (a) delivered personally, (b) delivered by a recognized overnight courier service, (c) sent by certified
mail, return receipt requested and first class postage prepaid, or (d) sent by facsimile transmission followed by a confirmation copy delivered by a recognized overnight courier service the next day. Such notices, demands and other communications
shall be sent to the address first set forth above, or to such other address or to the attention of such other person as the recipient party has specified by prior written notice to the sending party. Date of service of such notice shall be (i) the
date such notice is personally delivered or sent by facsimile transmission (with issuance by the transmitting machine of a confirmation of 
  

 5 

 successful transmission), (ii) the date of receipt if sent by certified mail, or (iii) the date of receipt if sent by
overnight courier. 
  
 6.10 Counterparts. This Agreement
may be executed in multiple counterparts, each of which shall be deemed an original and all of which taken together shall constitute one and the same Agreement. 
  

6.11 Descriptive Heading; Interpretation. The descriptive headings in this Agreement are inserted for convenience of reference only and are not
intended to be part of or to affect the meaning or interpretation of this Agreement. 
  
 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first above written. 
  

									
	 COMPANY:
	 	 	 	 PPD Development, LP

					
	 	 	 	 	 	 	By:	 	 PPD GP, LLC,

	 	 	 	 	 	 	 Its:
	 	 General Partner

					
	 	 	 	 	 	 	By:	 	 /s/ Fred N. Eshelman

	 	 	 	 	 	 	 Name:
	 	 Fred N. Eshelman

	 	 	 	 	 	 	 Title:
	 	 Chief Executive Officer

				
	 EMPLOYEE:
	 	 	 	By:	 	 /s/ Colin Shannon

	 	 	 	 	 	 	 Name:
	 	 Colin Shannon

  

 6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00073-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00073-of-00352.parquet"}]]